Primary Dysmenorrhea
Conditions
Brief summary
purpose of this study to investigate the effect of Extracorporeal shock wave therapy on pain and prostaglandin level in patient with primary dysmenorrhea
Detailed description
This randomized controlled trial is to determine the effect of shock wave therapy in the treatment of primary dysmenorrhea. females are randomly assigned into 2 groups: group A SWT treatment plus dietary modification during PD (n=25） GROUP B:dietary modification only (n=25）; Participants in group B will receive dietary modification for three successive months The numerical rating scale (NRS) and prostaglandin blood level will be recorded and evaluated before and after treatment.
Interventions
OTHERshock wave therapy
Intervention group is by shock wave therapy. A radial shock wave device (EME, ITALY) was used. for 4 sessions (one session before the expected day of period and session per day for day1 , day 2 and day 3 of each menstrual cycle) for three successive periods.
OTHERdietary modification
Participants will receive dietary modification for three consecutive months dietary modification will be low caffeine and high water and liquids intake and reduce the uptake of fast food, should be followed for 3 months
Sponsors
Ghada ebrahim El Refaye -Faculty of Physical Therapy, Cairo University, Egypt
Sohier Mahmmoud El Koseiry- Faculty of Physical Therapy, Cairo University, Egypt
MTI University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Intervention model description
group A: shockwave therapy and dietary modification group B: dietary modification
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 25 Years
Healthy volunteers
Yes
Inclusion criteria
1. ages ranged between18 - 25 years old. 2. body mass index (BMI) will not exceed 30kg/m2. 3. females will be diagnosed by the physician as primary dysmenorrhea.
Exclusion criteria
1. Secondary dysmenorrhea . 2. Mental health problem such as depression and anxiety. 3. Irregular periods
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| numerical rating scale | 3 months | Numeric rating scale will be 10 cm digital line with 0 (zero) representing feeling no pain and 10 representing feeling the worst pain, was used to assess the severity of the pain before and after treatment for all females in both groups (A&B). measurement will done twice first one at baseline(will be considered as pre treatment measure) and 2nd on e at 3rd menstrual cycle ( will be considered as post treatment measure) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| prostaglandin | 3months | 5cm plasma concentrations of prostaglandin F2α was taken from all females and was analyzed in the Laboratory index to determine the prostaglandin plasma level measurement will done twice before after the treatment program. |
Countries
Egypt
Outcome results
None listed